RPID · Rapid Micro Biosystems, Inc. · Webcasts, Transcripts & Audio
$0.79
+0.00 (+0.31%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$39.38M
Shares
50.16M
Volume · Oct 27
97.96K
Avg daily vol (3M)
243.26K
Rapid Micro Biosystems, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Rapid Micro Biosystems, Inc. (RPID), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-07
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call Transcript
Confident tone
Gross Margin Expansion
Quarterly Revenue and Operational Milestones
Recurring Revenue Growth
Revenue
$8.05M
▲ 10.9% YoY Diluted EPS
$-0.27
Gross margin
15.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Positive tone
Growth Direct system placements
Millipore Sigma collaboration
Gross margin expansion
Revenue
$8.00M
▲ 11.1% YoY Diluted EPS
$-0.31
Gross margin
4.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript
Confident tone
System placements & commercial wins
Gross margin expansion
Millipore Sigma collaboration
Revenue
$11.28M*
▲ 37.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-03-03
Rapid Micro Biosystems, Inc. (RPID) March 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-07
Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call Transcript
Confident tone
Multi-system record order
2026 growth drivers and outlook
Millipore Sigma partnership
Revenue
$7.84M
▲ 3.1% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Rapid Micro Biosystems, Inc. (RPID) Q2 2025 Earnings Call Transcript
Positive tone
Q2 Revenue and Recurring Revenue
Gross Margin Expansion
U.S. Pharma Manufacturing / Onshoring
Revenue
$7.26M
▲ 9.7% YoY Diluted EPS
$-0.27
Gross margin
3.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-09
Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
Confident tone
Quarterly Revenue and Execution
Gross Margin Expansion
GrowthDirect System and Validations
Revenue
$7.21M
▲ 28.4% YoY Diluted EPS
$-0.26
Gross margin
5.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-28
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
Confident tone
MilliporeSigma distribution and collaboration agreement
Quarterly and full-year revenue performance
2025 guidance and conservatism on outlook
Revenue
$8.22M*
▲ 29.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-01
Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript
Confident tone
Revenue growth and guidance
Gross margin improvement
System placements and land-and-expand
Revenue
$7.60M
▲ 23.7% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-02
Rapid Micro Biosystems, Inc. (RPID) Q2 2024 Earnings Call Transcript
Confident tone
2024 guidance and outlook
System placements and Growth Direct adoption
Operational efficiency and cash management
Revenue
$6.62M
▲ 32.3% YoY Diluted EPS
$-0.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-03
Rapid Micro Biosystems, Inc. (RPID) Q1 2024 Earnings Call Transcript
Confident tone
Growth Direct System Placements and Adoption
Recurring and Consumable Revenue
Gross Margin Improvement
Revenue
$5.61M
▲ 11.4% YoY Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-01
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
Confident tone
Growth Direct system placements
Gross margin improvement
2024 guidance and financial outlook
Revenue
$6.34M*
▲ 44.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Rapid Micro Biosystems, Inc. (RPID) Q3 2023 Earnings Call Transcript
Revenue
$6.14M
▲ 29.7% YoY Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-04
Rapid Micro Biosystems, Inc. (RPID) Q2 2023 Earnings Call Transcript
Revenue
$5.00M
▲ 29.6% YoY Diluted EPS
$-0.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-05
Rapid Micro Biosystems, Inc. (RPID) Q1 2023 Earnings Call Transcript
Revenue
$5.04M
▲ 21% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-03
Rapid Micro Biosystems, Inc. (RPID) Q4 2022 Earnings Call Transcript
Revenue
$4.37M*
▼ 16% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Rapid Micro Biosystems, Inc. (RPID) Q3 2022 Earnings Call Transcript
Revenue
$4.74M
▼ 31.3% YoY Diluted EPS
$-0.38
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Rapid Micro Biosystems, Inc. (RPID) Q2 2022 Earnings Call Transcript
Revenue
$3.86M
▼ 37% YoY Diluted EPS
$-0.31
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Rapid Micro Biosystems, Inc. (RPID) Q1 2022 Earnings Call Transcript
Revenue
$4.16M
▼ 16.7% YoY Diluted EPS
$-0.35
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-04
Rapid Micro Biosystems, Inc. (RPID) Q4 2021 Earnings Call Transcript
Revenue
$5.21M*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-12
Rapid Micro Biosystems, Inc. (RPID) Q3 2021 Earnings Call
Revenue
$6.90M
▲ 31.5% YoY Diluted EPS
$-0.71
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-26
Rapid Micro Biosystems, Inc. (RPID) Q2 2021 Earnings Call
Revenue
$6.13M
▲ 136.4% YoY Diluted EPS
$-20.01
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–22 of 22 webcasts
Key facts
CIK
1380106
CUSIP
75340L104
13F (30d)
22 filings
5 filers
Visit website
Investor relations